Definition of the immune evasion-replication interface of rabies virus P protein.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2021
Historique:
received: 02 02 2021
accepted: 18 06 2021
revised: 20 07 2021
pubmed: 9 7 2021
medline: 25 2 2023
entrez: 8 7 2021
Statut: epublish

Résumé

Rabies virus phosphoprotein (P protein) is a multifunctional protein that plays key roles in replication as the polymerase cofactor that binds to the complex of viral genomic RNA and the nucleoprotein (N protein), and in evading the innate immune response by binding to STAT transcription factors. These interactions are mediated by the C-terminal domain of P (PCTD). The colocation of these binding sites in the small globular PCTD raises the question of how these interactions underlying replication and immune evasion, central to viral infection, are coordinated and, potentially, coregulated. While direct data on the binding interface of the PCTD for STAT1 is available, the lack of direct structural data on the sites that bind N protein limits our understanding of this interaction hub. The PCTD was proposed to bind via two sites to a flexible loop of N protein (Npep) that is not visible in crystal structures, but no direct analysis of this interaction has been reported. Here we use Nuclear Magnetic Resonance, and molecular modelling to show N protein residues, Leu381, Asp383, Asp384 and phosphor-Ser389, are likely to bind to a 'positive patch' of the PCTD formed by Lys211, Lys214 and Arg260. Furthermore, in contrast to previous predictions we identify a single site of interaction on the PCTD by this Npep. Intriguingly, this site is proximal to the defined STAT1 binding site that includes Ile201 to Phe209. However, cell-based assays indicate that STAT1 and N protein do not compete for P protein. Thus, it appears that interactions critical to replication and immune evasion can occur simultaneously with the same molecules of P protein so that the binding of P protein to activated STAT1 can potentially occur without interrupting interactions involved in replication. These data suggest that replication complexes might be directly involved in STAT1 antagonism.

Identifiants

pubmed: 34237115
doi: 10.1371/journal.ppat.1009729
pii: PPATHOGENS-D-21-00257
pmc: PMC8291714
doi:

Substances chimiques

Molecular Chaperones 0
Nucleocapsid Proteins 0
P phosphoprotein, Rabies virus 0
STAT1 Transcription Factor 0
Viral Structural Proteins 0
nucleocapsid protein, Rabies virus 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009729

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Virol. 2002 May;76(9):4153-61
pubmed: 11932380
J Virol. 2001 Oct;75(20):9613-22
pubmed: 11559793
Science. 2006 Jul 21;313(5785):360-3
pubmed: 16778023
J Virol. 2011 Aug;85(15):7555-62
pubmed: 21593149
J Virol. 1974 Nov;14(5):1253-61
pubmed: 4372398
Biomol NMR Assign. 2019 Apr;13(1):5-8
pubmed: 30238347
Wkly Epidemiol Rec. ;92(7):77-86
pubmed: 28211265
PLoS Pathog. 2020 Sep 9;16(9):e1008767
pubmed: 32903273
Bioinformatics. 2015 Apr 15;31(8):1325-7
pubmed: 25505092
Science. 2010 Feb 5;327(5966):689-93
pubmed: 20133572
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
J Virol. 2013 Jul;87(14):8261-5
pubmed: 23698294
J Gen Virol. 2008 Jan;89(Pt 1):1-47
pubmed: 18089727
PLoS Pathog. 2009 Feb;5(2):e1000315
pubmed: 19247444
J Biomol NMR. 2014 Feb;58(2):129-39
pubmed: 24435565
Arch Virol. 2018 Aug;163(8):2283-2294
pubmed: 29637429
Biochem Biophys Res Commun. 2020 Aug 20;529(2):507-512
pubmed: 32703459
J Biomol NMR. 2003 Mar;25(3):173-95
pubmed: 12652131
Biochem Biophys Res Commun. 2003 May 2;304(2):333-8
pubmed: 12711319
Angew Chem Int Ed Engl. 2011 Jun 6;50(24):5556-9
pubmed: 21538743
J Mol Biol. 2004 Oct 29;343(4):819-31
pubmed: 15476803
Cell. 1985 May;41(1):259-67
pubmed: 2986844
Nat Struct Biol. 2001 Sep;8(9):756-60
pubmed: 11524676
J Biol Chem. 2012 Aug 10;287(33):28112-21
pubmed: 22700958
Virus Res. 2011 Dec;162(1-2):126-37
pubmed: 21963663
J Virol. 2012 Sep;86(18):10194-9
pubmed: 22740405
J Virol. 2005 Nov;79(22):14411-20
pubmed: 16254375
Sci Rep. 2019 Jul 3;9(1):9639
pubmed: 31270364
J Virol. 2001 Jan;75(1):490-8
pubmed: 11119617
PLoS Pathog. 2013;9(9):e1003631
pubmed: 24086133
Nat Mater. 2018 Aug;17(8):740-746
pubmed: 29967464
J Vet Med Sci. 2016 Aug 1;78(7):1089-98
pubmed: 27041139
Proc Natl Acad Sci U S A. 1986 Jun;83(11):3914-8
pubmed: 3459163
Biochemistry. 2007 Oct 30;46(43):12053-61
pubmed: 17924652
BMC Res Notes. 2012 Jul 23;5:367
pubmed: 22824207
Virology. 2005 Apr 10;334(2):284-93
pubmed: 15780878
J Virol. 2020 Oct 27;94(22):
pubmed: 32847860
J Virol. 2003 Jul;77(13):7635-44
pubmed: 12805463
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
Protein Sci. 2006 Dec;15(12):2795-804
pubmed: 17088319
J Am Chem Soc. 2010 Feb 24;132(7):2145-7
pubmed: 20121194
Cell Rep. 2019 Nov 12;29(7):1934-1945.e8
pubmed: 31722208
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20006-11
pubmed: 23150595
J Virol. 2010 Jul;84(13):6699-710
pubmed: 20427527
Microbiol Immunol. 1994;38(6):449-55
pubmed: 7526134
Trends Biochem Sci. 2006 Aug;31(8):436-44
pubmed: 16828554
Nucleic Acids Res. 2004 Aug 10;32(14):e115
pubmed: 15304544
J Virol. 1999 Sep;73(9):7199-209
pubmed: 10438807
Virology. 1981 Oct 30;114(2):555-62
pubmed: 6270887
PLoS One. 2016 Mar 03;11(3):e0150477
pubmed: 26939125
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709
pubmed: 25881058
J Mol Biol. 1991 Nov 20;222(2):311-33
pubmed: 1960729
PLoS Comput Biol. 2009 Mar;5(3):e1000307
pubmed: 19282963
Microbiol Immunol. 2005;49(8):757-70
pubmed: 16113504
Virology. 1990 Apr;175(2):485-99
pubmed: 2139267
J Virol. 2003 Jun;77(11):6385-93
pubmed: 12743296
J Virol. 1998 Mar;72(3):1925-30
pubmed: 9499045
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
Microbiol Immunol. 2004;48(5):399-409
pubmed: 15215627
Biochim Biophys Acta Mol Cell Res. 2020 Dec;1867(12):118831
pubmed: 32835749
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11713-8
pubmed: 19571006
Virology. 2004 Jan 20;318(2):463-73
pubmed: 15015496
Nat Commun. 2017 Jul 5;8(1):58
pubmed: 28680096
World Health Organ Tech Rep Ser. 2013;(982):1-139, back cover
pubmed: 24069724
J Virol. 2010 Jan;84(2):1089-96
pubmed: 19906936
PLoS Pathog. 2021 Jun 24;17(6):e1009636
pubmed: 34166464
Sci Rep. 2016 Sep 21;6:33493
pubmed: 27649849
J Mol Biol. 2017 Feb 3;429(3):365-371
pubmed: 27964945
J Virol. 2007 Apr;81(8):4255-63
pubmed: 17287281
J Mol Biol. 2009 Dec 4;394(3):558-75
pubmed: 19781554
J Biomol NMR. 2001 May;20(1):71-5
pubmed: 11430757
J Virol. 1970 Nov;6(5):677-84
pubmed: 4320701
J Struct Biol. 2007 Apr;158(1):129-33
pubmed: 17126031
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5655-9
pubmed: 2441389
J Virol. 2007 Jul;81(13):6807-16
pubmed: 17459940
J Infect Dis. 2014 Jun 1;209(11):1744-53
pubmed: 24367042
J Virol. 2015 Feb;89(3):1939-43
pubmed: 25428867
Sci Rep. 2016 Apr 25;6:24826
pubmed: 27109776
Protein Expr Purif. 2005 May;41(1):207-34
pubmed: 15915565
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
J Virol. 2009 Aug;83(16):7948-58
pubmed: 19494013

Auteurs

Jingyu Zhan (J)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Angela R Harrison (AR)

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.

Stephanie Portelli (S)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Thanh Binh Nguyen (TB)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Isshu Kojima (I)

Joint Graduate School of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.

Siqiong Zheng (S)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Fei Yan (F)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Tatsunori Masatani (T)

Laboratory of Zoonotic Diseases, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.

Stephen M Rawlinson (SM)

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.

Ashish Sethi (A)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Naoto Ito (N)

Laboratory of Zoonotic Diseases, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.

David B Ascher (DB)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Gregory W Moseley (GW)

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.

Paul R Gooley (PR)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH